GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HAEMATO AG (XTER:HAEK) » Definitions » 5-Year Yield-on-Cost %

HAEMATO AG (XTER:HAEK) 5-Year Yield-on-Cost % : 5.61 (As of May. 12, 2024)


View and export this data going back to 2005. Start your Free Trial

What is HAEMATO AG 5-Year Yield-on-Cost %?

HAEMATO AG's yield on cost for the quarter that ended in Jun. 2023 was 5.61.


The historical rank and industry rank for HAEMATO AG's 5-Year Yield-on-Cost % or its related term are showing as below:

XTER:HAEK' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 3.7   Med: 5.86   Max: 21.13
Current: 5.61


During the past 13 years, HAEMATO AG's highest Yield on Cost was 21.13. The lowest was 3.70. And the median was 5.86.


XTER:HAEK's 5-Year Yield-on-Cost % is ranked better than
86.65% of 502 companies
in the Drug Manufacturers industry
Industry Median: 2.135 vs XTER:HAEK: 5.61

Competitive Comparison of HAEMATO AG's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, HAEMATO AG's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HAEMATO AG's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HAEMATO AG's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where HAEMATO AG's 5-Year Yield-on-Cost % falls into.



HAEMATO AG 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of HAEMATO AG is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

HAEMATO AG  (XTER:HAEK) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


HAEMATO AG 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of HAEMATO AG's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


HAEMATO AG (XTER:HAEK) Business Description

Traded in Other Exchanges
Address
Lilienthalstrasse 5c, Schonefeld, DEU, D-12529
HAEMATO AG is a Germany based pharmaceutical company. It provides pharmaceuticals for the care of chronically ill people. The firm is engaged in the sale of generic and EU (European countries) import drugs. It is focused on patented and non-patented medicinal products. The company product portfolio includes human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), neurology, oncology, rheumatology, and urology. Geographically, it operates only in Germany.

HAEMATO AG (XTER:HAEK) Headlines

No Headlines